Baralex Overview

  • Founded
  • 1956
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Buyout/​LBO
  • Financing Rounds
  • 1

Baralex General Information

Description

Supplier of ingredients and value-added products to pharmaceutical and health supplement manufacturers. The company sources and markets a selective range of products, together with technical support to meet all regulatory, analytical and manufacturing requirements. It also manufactures and supplies a wide range of raw material drug master files (DMF's) for molecules.

Contact Information

Website
www.baralex.com
Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
  • 16 667 Hymus Boulevard
  • Kirkland, Quebec H9H 4R9
  • Canada
+1 (514) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Baralex Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Baralex‘s full profile, request access.

Request a free trial

Baralex Executive Team (1)

Name Title Board Seat Contact Info
Alex Eastwood President
To view Baralex’s complete executive team members history, request access »

Baralex Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Baralex‘s full profile, request access.

Request a free trial